Educate
Learn with us
Advocate
Discover your voice
Connect
Get involved! Serve on a team
AzPA Pharmacy Flash
- Novartis sickle cell drug wins FDA approvalNovartis' treatment is an antibody that blocks the action of a protein called P-selectin, which can cause blood cells to stick to each other and cells in blood vessel walls. The sticking can in turn trigger a vaso-occlusive crisis, which may cause pain and lead to costly hospitalizations, or even death.
- New, online resource designed to assist pharmacists with CBD productsThe National Community Pharmacists Association (NCPA) has launched a new resource for pharmacists looking to understand and purchase reliable cannabidiol (CBD) products, called the NCPA CBD Source. The online resource features CBD products that have been tested for concentrations of all cannabinoids, including CBD and tetrahydrocannabinol (THC), by an independent, third-party lab.
- Study: USP quality standards support US generics marketA new study released in the journal PLOS One found that on average, drugs with a public quality standard developed by the U.S. Pharmacopeia had approximately 50% more generic manufacturers compared with medicines without such a standard.
